Citadel Advisors’s BioXcel Therapeutics BTAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,156
Closed -$12.9K 14524
2024
Q4
$12.9K Buy
2,156
+768
+55% +$6.42K ﹤0.01% 13478
2024
Q3
$13.5K Buy
1,388
+107
+8% +$1.44K ﹤0.01% 13058
2024
Q2
$26.2K Buy
1,281
+537
+72% +$18K ﹤0.01% 12399
2024
Q1
$33.6K Sell
744
-2,850
-79% -$136K ﹤0.01% 12581
2023
Q4
$170K Buy
3,594
+1,506
+72% +$83.7K ﹤0.01% 10203
2023
Q3
$84.5K Sell
2,088
-4,087
-66% -$413K ﹤0.01% 11099
2023
Q2
$658K Buy
6,175
+3,594
+139% +$1.2M ﹤0.01% 7333
2023
Q1
$771K Sell
2,581
-3,275
-56% -$1.4M ﹤0.01% 7366
2022
Q4
$2.01M Sell
5,856
-869
-13% -$210K ﹤0.01% 5476
2022
Q3
$1.27M Buy
6,725
+500
+8% +$116K ﹤0.01% 6478
2022
Q2
$1.31M Buy
6,225
+1,144
+23% +$241K ﹤0.01% 6411
2022
Q1
$1.7M Sell
5,081
-1,638
-24% -$475K ﹤0.01% 6454
2021
Q4
$2.19M Buy
6,719
+2,188
+48% +$939K ﹤0.01% 6029
2021
Q3
$2.2M Buy
4,531
+1,800
+66% +$791K ﹤0.01% 6109
2021
Q2
$1.27M Buy
2,731
+150
+6% +$81.8K ﹤0.01% 7728
2021
Q1
$1.78M Sell
2,581
-1,963
-43% -$1.58M ﹤0.01% 6680
2020
Q4
$3.36M Buy
4,544
+1,356
+43% +$1.06M ﹤0.01% 4386
2020
Q3
$2.21M Buy
3,188
+1,344
+73% +$1.01M ﹤0.01% 4535
2020
Q2
$1.56M Buy
1,844
+538
+41% +$351K ﹤0.01% 4995
2020
Q1
$467K Buy
+1,306
New +$469K ﹤0.01% 6561

Other funds holding BTAI